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Graft versus host reactions have been encountered  in  several situations  in 
which recipient animals have been unable to defend themselves against grafts of 
immunologically competent foreign ceils.  Such reactions follow the grafting of 
genetically different adult lymphoid cells to embryos and newborns and have 
been  termed  "runting  disease"  (1-5).  A  graft versus host  syndrome can  be 
induced in adult F1 hybrid animals by the administration of large numbers of 
lymphoid  ceils  from either  of  its  homozygous parent  strains  (6,  7).  Similar 
evidences of an immunologic attack by either parent on Fx hybrids have been 
shown  following  parabiotic  union  (8,  9).  Further,  graft versus  host  disease 
follows the transfer of foreign immune competent cells to adult  animals pre- 
viously treated with lethal doses of whole body irradiation (10, 11) or who had 
been thymectomized shortly after birth (12). 
In the present studies the occurrence of a graft versus host disease is described 
in a  somewhat different experimental system. An acute immunologic reaction 
against adult  Fx hybrid mice is shown to follow the  grafting of a  variety of 
parental, allogeneic, and xenogeneic immunologically responsive cells to cyclo- 
phosphamide-treated recipients. 
Materials  and Methods 
Animals.l--Female BDF1 (C57BL/6 X  DBA/2)  mice, age 10-12 wk, were used as re- 
cipients. Donor mice of similar sex and age were chosen from the C57BL/6, DBA/2, C3H, 
and BALB/c strains. Rat bone marrow cells were obtained from Sprague-Dawley females, 
age 10--12  wk. All animals were housed in covered plastic cages, 10 or fewer per cage, and pro- 
vided with tap water and a standard laboratory diet  2 ad lib. 
Dmg.a--Cyclophosphamide (CY) mad mechlorethamine (HN2) were dissolved in saline 
and used within 10 rain. 
* These studies were supported by Public Health Service Grants CA-6973 and CA-5091, 
and Research Career Development Award K3-CA-25,344. 
The work was previously presented in part in 1963. Federation Proc. 22".393. 
1 Inbred  mice were obtained from  the  Roscoe B.  Jackson Memorial Laboratory,  Bar 
Harbor, Me., and Microbiologic Associates, Inc., Bethesda, Md. 
2 Purina Chow Checkers. 
3 Drugs were supplied generously  by the Cancer Chemotherapy National Service Center. 
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Cell Preparations.--Peripheral  blood was  collected  by  bleeding from  the  retro-orbital 
venous plexus under light ether anesthesia. The nucleated leukocytes were separated, washed, 
and concentrated in cold Tyrode's solution as described previously (13). 
Donor animals for other cells were killed by cervical dislocation. Spleens were minced with 
a fine scissors and gently homogenized with a loose fitting glass TenBroeck homogenizer.  The 
crude spleen cell  suspension was faltered  through surgical gauze,  washed,  and finally sus- 
pended in cold Tyrode's solution (13). Thymus tissue was dissected from the mediastinum and 
cell suspensions were prepared as from spleens. Bone marrow was obtained from the femurs. 
The pulpy marrow was dissociated by gentle agitation, filtered through surgical gauze, washed, 
and the cells finally suspended in cold Tyrode's solution (13) .... 
Nucleated cell suspensions were counted with a standard clinical hemocytometer. Trypan 
blue dye exclusion was used to assess the number of "viable" ceils (13, 14). Peripheral blood 
cell suspensions were 3-5% trypan blue positive, bone marrow suspensions 10-15% positive, 
and spleen and thymus cell preparations 20-25% positive. Cell suspensions were injected into 
a tail vein in a volume of 0.S ml except at the highest cell dose levels, where 1.0 ml was used. 
All cell doses were calculated as viable cells. 
Wright's stain was used to distinguish morphologic  cell types. The alkaline phosphatase 
stain was used to identify rat polymorphonuclear leukocytes (10, 1S). 
Basic Experimental Protocd.--Prospectlve  recipient mice were treated with graded single 
doses of cyclophosphamide or mechlorethamine injected intraperitoneally  on day 0. 24 hr later 
(day 1), donor cell suspensions were administered slowly by a  single intravenous injection. 
The mice were observed daily for a 60 day period and weighed three times weekly. 
This study is based on several series of experiments. In each series a single experimental 
variable was examined and its controls were  evaluated concurrently. Each series of studies 
was repeated at least two or three times and, unless otherwise  noted, final statistical analysis 
was not completed until each experimental point comprised 30-40 mice. 
Experimental controls were employed as indicated. At times, isotonic saline was used in 
place of cydophosphamide or mechlorethamine. The several controls used in place of donor 
cell suspensions included isotonic saline, cell preparations lysed in hypotonic aqueous solution 
and cell suspensions heated at 56°C for 20 rain. In some experiments viable isogeneic cells 
were given in place of similar foreign cells. 
Statistical Analysis.4---All regression fines were fitted by the method of least squares and 
their slopes determined. Statistical methodology is based on standard texts and has been de- 
scribed previously (16). The method of Berkson (17) was used to calculate the i~  values. 
l~SULTS 
Mice  given  cyclophosphamide  and  mature  foreign  nucleated  cells  rapidly 
developed a  characteristic clinical illness which resembled the graft versus host 
disease encountered in studies of radiation chimeras and in FI hybrid mice who 
had received large doses of parental lymphoid cells. Within 5-I0 days of receiv- 
ing the foreign cells, the affected animals became very lethargic and assumed a 
hunched posture. Their fur was ruffled and unkempt and their faces were often 
edematous.  Crusted secretions frequently formed about the eyes and perianal 
area.  These  mice moved about with a  peculiar,  unsteady,  high-stepping gait. 
Severe wasting developed, animals often losing more than 25 %  of their initial 
4 Analysis of the data was facilitated by the Computing Center of the Johns Hopkins 
Medical  Institutions which  is  supported  by  United  States  Public Health  Service  Grant 
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body weight. Although the stools were sometimes soft and sticky, diarrhea was 
not  a  prominent feature of  this  syndrome. Neither  did a  clinically evident 
generalized dermatitis develop with any characteristic frequency. 
The more severely affected animals began to die within 5-7 days and deaths 
continued to occur through days 25-30.  Only rarely were additional deaths 
observed between days 30 and 60. Mice developing a milder form of the disorder 
recovered spontaneously, usually within the 3rd-6th  wk of observation.  At 
autopsy, the severely wasted animals appeared pale, but not icteric. The thy- 
mus and lymph nodes were unusually small. The spleen was of variable size, 
enlarged in the mice dying earlier in the course of the illness and small in 
animals dying later. In general, histologic study revealed tissue changes similar 
to those reported in other types of graft versus host disease. 
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Fro. 1. The effect  of cyclophosphamide  dosage on mortality due to graft versus host dis- 
ease. The fate of drug-treated mice given 16 >( l0  s spleen cells from C57BL/6 or DBA/2 
donors is compared with that of mice given graded doses of cyclophosphamide  alone. 
Effect o/Drug  Treatment.--Several experiments  were  performed in  which 
groups of BDFx mice were given graded single doses of cyclophosphamide rang- 
ing from 50 to 600 mg per kg. 24 hr later they received a graft of 16 X  106 nu- 
cleated spleen cells from the C57BL/6, DBA/2, or C3H  strains. Other BI)Fz 
mice were given similar graded doses of cyclophosphamide, but saline instead 
of spleen cells. 
When compared with animals treated with cyclophosphamide and saline, an 
increased mortality was observed in those groups given cyclophosphamide and 
parental spleen cells  (Fig. I). Similar results were encountered in mice given 
cyclophosphamide and C3H spleen  cells.  The clinical course of the animals 
developing the wasting syndrome as described previously could be distinguished 
from the effects caused by cyclophosphamide alone (Table I). A positive dose- 
response relationship existed between the level of the cyclophosphamide dose 280  GRAFT VERSUS  HOST  DISEASE  AND  CYCLOPHOSPHAMIDE 
and the severity of this wasting syndrome. Mice given isotonic saline in place 
of  cyclophosphamide  developed  no  apparent  illness  when  given  16  X  l0  s 
C57BL/6,  DBA/2,  or C3H  spleen cells 1  day later. 
In a  similar series of experiments, BDF1 mice were given graded single doses 
of mechlorethamine ranging from 2 to 16 mg per kg. 24 hr later they received 
TABLE I 
The Effect of Parental and Allogeneic Spleen Cells on Mortality Caused by Graded 
Doses of Cydophosphamide 
Mortality* 
Donor strain 
(16 X 108 cells) 
LD10 -~- SE  I,DJ0 ::J:: SE  L])ll0 "J'-  SE 
O 
C57BL/6 
DBA/2 
C3H 
278  4-  28 
95  4-  17 
111  4-  13 
98  4-  16 
411  -4-  26 
210  4-  16 
196  4-  12 
213  4-  18 
608  4-  109 
463  4-  84 
343  4-  37 
423  4-  64 
* Dose of cyclophosphamide  (rag per kg) required to kill 10, 50, and 90% of mice. 
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Fro. 2. The effect of mechlorethamine  on the induction of graft versus host disease. The 
fate of drug-treated mice given  16  X  106 spleen cells from C57BL/6,  DBA/2, and BDF1 
donors is the same as those given graded doses of mechlorethamine  alone. 
16  X  106 nucleated spleen cells from C57BL/6, or DBA/2 donors. Additional 
groups of BDF1 mice were given identical graded doses of mechlorethamine, but 
saline in place of spleen cells. The clinical course and mortality encountered in 
mice  receiving mechlorethamine  and  spleen  cells could not  be  distinguished 
from  comparable groups given drug  alone (Fig.  2).  No stigmata of the graft 
versus host reaction were apparent. 
Effect of Parental Cells.--In  a  second series of experiments several groups of ALBERT H.  OW'ENS~ JR.~ AND GEORGE W.  SANTOS  281 
BDF1 mice were treated with a single dose of cyclophosphamide, 300 mg per kg. 
24 hr later these mice were given graded doses of spleen cells ranging from 4 to 
32  X  10  e nucleated cells. Donor animals were from either parental  strain,  the 
C57BL/6, or DBA/2. 
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FIG. 3. The effect of C57BL/6 spleen cells on the induction  of graft versus host disease 
The fate of drug-treated  mice given graded doses of cells is compared with those receiving 
cyclophosphamide, 300 mg per kg, alone. 
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FIG. 4.  The effect of DBA/2 spleen cells on the induction of graft versus host disease. The 
fate of drug-treated  mice given graded doses of cells is compared with those receiving cyclo- 
phosphamide, 300 mg per kg, alone. 
The severe wasting of the graft versus host reaction was apparent in the mice 
treated with cyclophosphamide and spleen cells and could be distinguished from 
the effects of cyclophosphamide alone. The cumulative mortality caused by this 
rather  acute graft versus host reaction is  shown in Figs.  3  and 4.  These data 282  GRAFT  VERSUS  HOST  DISEASE  AND  CYCLOPHOSPHAI~IDE 
also indicate a positive relationship between the size of the spleen cell inoculum 
and the resultant  severity of the graft versus host disease.  Cells derived from 
either  parental  strain  produced  similar  results  (Table  II).  Although  DBA/2 
spleen cells would appear to be six or seven times more potent than those from 
TABLE II 
Mortality Due to Graded Doses o/Isogeneic, Parental, and Allogeneic Spleen Cells in 
Mice Pretreated with Cydophospharaide 
Donor strain 
(4-64 X  100 cells) 
BDF1 
C57BL/6 
DBA/2 
C3H 
BALB/c 
Mortality* 
LD10 "-!- SE  ]51)50  4.  SE  LDg0 -4- SE 
4.4  4- 0.65 
0.08  4.  0.2 
0.5  4.  0.4 
1.6  4- 0.6 
No dose effect seen 
10.0  ±  0.8 
1.5  4.  1.3 
4.0+  1.1 
7.9  -4- 1.0 
22.5  -4- 4.0 
31  4-  20 
32  ±  12 
38  =k  13 
* Number of cells 106 required to kill 10, 50, and 90% d  mice. 
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I~o. 5. The effect of C3H spleen cells on the induction of graft versus host disease. The 
fate of drug-treated  mice given graded doses of cells is compared with those receiving cyclo- 
phosphamide, 300 nag per kg, alone. 
the C57BL/6,  such a comparison was not thought trustworthy since interstrain 
experiments were not performed concurrently. 
Graft versus host disease  did not occur when  animals  were given lysed or 
heated spleen ceils. Neither was it seen in mice given 32 X  106 nucleated spleen 
ceils  from  either  parent  in  the  absence  of  cyclophosphamide  pretreatment. 
Effect of AUogeneix Cells.--In  a  third  series of experiments groups of BDFt 
mice were given a single dose of cyclophosphamide, 300 mg per kg, 24 hr before 
graded inocula of allogeneic spleen cells.  The dose levels of spleen cells ranged ALBERT  H.  OWENS~  J~., AND  GEORGE  W.  SANTOS  283 
from 4  to 64 X  106 nucleated cells.  Donor animals were from the C3H and 
BALB/c strains. 
Animals treated with cyclophosphamide and "viable" spleen cells developed 
the characteristic clinical manifestations of the graft versus host reaction. The 
resultant illness was more severe in those mice given the larger doses of spleen 
cells (Figs. 5 and 6). One could not distinguish clearly between the consequences 
of spleen cell grafts from the C3H or BALB/c strains  (Table II). 
No clinical evidence of the graft versus host reaction was  detected in the 
animals treated with cyclophosphamide alone. Neither was this syndrome seen 
in mice given 64  X  106 C3H or BALB/c spleen cells without drug pretreat- 
ment. 
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FIG. 6. The effect  of BALB/c spleen cells  on the induction of graft versus host disease. The 
fate of drug-treated mice given graded doses of cells is compared with those receiving  cyclo- 
phosphamide, 300 mg per kg, alone. 
Effect of Xenogeneic Cells.--The graft versus host disease also developed in 
BDF1 mice treated with cyclophosphamide, 300 mg per kg, and given rat bone 
marrow, 70 or 140 X  106 viable nucleated cells, 24 hr later. A clear-cut but less 
severe wasting syndrome occurred in animals pretreated with a smaller dose of 
cyclophosphamide, 200  mg  per  kg,  prior  to grafting  (Table III).  Although 
allogeneic mouse marrow cells (Fig.  7)  appear to be four to five times more 
capable of inducing graft versus host disease than cells from rat marrow when 
given to recipients pretreated with cyclophosphamide, 300 nag per kg,  such 
a comparison would not seem valid since the interspecies comparisons were not 
completed concurrently. 
When recipient mice were pretreated with mechloretbamlne, 6 mg per kg or 
given isotonic saline 24 hr before the rat marrow grafts, no evidence of the graft 
versus host reaction developed. Further, this type of wasting syndrome was not 284  GRA~  VERSUS  HOST  DISEASE  AND  CYCLOPHOSPHAMIDE 
seen following the administration of rat bone marrow, 140 X  108 nucleated ceils, 
without cyclophosphamide pretreatment  (Table III). 
In a  similar  series  of experiments,  BDFI mice given cyclophosphamide or 
mechlorethamine and rat bone marrow cells were examined for the persistence 
TABLE III 
Mortality Encountered in Mice Treated with Cyclopkospkaraide or Mecldorethamine 
and Rat Bone Marrow 
Bone marrow  No. mice  Mortality  Pretteatment drug  (nucleated  cells) 
%  mg/kg 
Cydophosphamide 
300 
300 
3OO 
200 
200 
200 
Mechlorethamine 
6 
6 
6 
None 
140 X  106 
70 X  i0  e 
0 
140 X  I0  ° 
70 X  I06 
0 
140 X  106 
70 X  l0  s 
0 
140 X  106 
12 
9 
10 
13 
10 
10 
13 
9 
10 
8 
100 
78 
20 
46 
50 
0 
23 
33 
30 
0 
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FIG. 7. A comparison of the fate of drug-treated mice given graded doses of nucl~ted cells 
from the peripheral blood, spleen, bone marrow, and thymus of C57BL/6 donors and those 
receiving cyclophosphamide, 300 nag per kg, alone. 
of rat polymorphonuclear leukocytes in their peripheral blood, spleen,  and bone 
marrow. The alkaline phosphatase staining reaction was used to distinguish the 
presence of rat granulocytes, since mouse cells are not stained by this technique 
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It  would  appear  that  rat  polymorphonuclear  leukocytes were  promptly 
disposed of by recipient mice who were given no drug pretreatment or by those 
who received mechlorethamine (Table IV).  In  none  of these  animals could 
alkaline phosphatase--positive granulocytes  be detected in the blood, spleen,  or 
marrow 48 hr after the graft. In contrast, in mice pretreated with cyclophos- 
phamide, alkaline phosphatase-positive cells were detected for at least 14 days. 
These foreign cells more frequently persisted in animals treated with the higher 
dose of cyclophosphamide and given the larger inoculum of rat bone marrow. 
Effects  of Grafts from  Various  T/ssues.--The  ability of cells  from  various 
foreign tissues to induce the graft versus host syndrome was examined in a 
fifth set of experiments. In this series recipient BDFx mice were treated with a 
TABLE IV 
Persistence of Rat Polymorpkonuctear Leukocytes in the Tissues of Mice Given 
Cyclophos ~kamide or Mechloretkamine and Rat Bone Marrow 
Pretre~tme~t drug 
m/ks 
Cydophosphamide 
300 
300 
3O0 
2O0 
Mechlorethamlne 
6 
6 
None 
Rat bone marrow 
(nucleated cells) 
140 X 10  6 
70 X 10  e 
0 
140 X  10 6 
140 X 10  e 
0 
140 X 10  6 
Persistence of rat cells (days after transfer) 
9/9* 
9/9 
0/io 
o/ll 
o/lo 
o/lo 
7/8 
6/i0 
2/10 
10 
819 
1/7 
1/6 
14 
6/6 
0/9 
* Number of mice with alkaline phosphatase-positive granulocytes  per number of mice 
examined. 
single dose of cydophosphamide, 300 mg per kg, 24 hr prior to receiving a sus- 
pension of cells from C57BL/6 (parental) donors. Graded inocula of cells were 
prepared  from the  peripheral  blood  (range 0.25-1.5  X  106), spleen  (range 
1-32 X  106), bone marrow (range 2-32 X  106), and thymus (range 8-64 X  106). 
The characteristic clinical manifestations of the graft versus host reaction 
were noted in all experimental groups given cyclophosphamide and inocula of 
viable nucleated cells. The mortality due to this immunologic disorder could be 
readily related to the size of the foreign cell graft (Fig. 7). It would appear that 
cells from the peripheral blood were most capable of inducing the graft versus 
host disease and those from the thymus least effective. Cells from the spleen 
and bone marrow were of intermediate potency, the spleen cells appearing some- 
what more effective (Table V).  Since the thymus cell suspensions were not 
visibly hemoglobin stained, it seems unlikely that their effect resulted solely 
from contamination by peripheral blood (13). 286  GI~FT  VERSUS  HOST  DISEASE  AND  CYCLOPHOSPHAMIDE 
Experimental Controls.--In each series of experiments a  number of controls 
were used in place of drug treatment or the grafts of viable cells. They may be 
listed as follows: 
1.  Isotonic saline was substituted for cyclophosphamide or mechlorethamine 
pretreatment in animals being given the largest dose of nucleated cells under 
evaluation (cells alone control). 
2.  Equivalent cell preparations,  previously lysed by water,  were given in 
place of the largest inoculum of cells being studied (lysed cell control). 
3.  Cell suspensions equal to the largest inoculum being studied were heat- 
killed prior to injection in place of viable cells (heat-killed cell control). 
4.  Isotonic saline was substituted also for the cell suspension in each series of 
trims (drug alone control). 
TABLE  V 
Mortality Due to Graded Doses of Parental  Cells in Mice Prareated with Cydophosphamide 
Mortality* 
Tissue source 
(C~7BL/6 donor) 
LD10 q" SE  LDs0  -4-  SE  LD0o  --4- SE 
Blood  0.2  4- 0.06  0.8  4- 0.09  2.6  4-  1.0 
Spleen  2.0  4- 0.3  4.0  4- 0.3  7.9  4-  1.2 
Marrow  6.6  4-  1.0  11.3 -4- 0.9  19  4-  2.8 
Thymus  32  4-  8  84  4-  9  217  4-  58 
* Number of cells 10  s required to kill 10, 50, and 90% of mice. 
In none of these control groups were evidences of the graft versus host disease 
observed. 
Additional  studies  were  completed  in  mice  given  isogeneic  (BDF1)  cells 
equivalent in  tissue type and amount to the foreign grafts being used.  In no 
instance did the severe wasting syndrome develop in animals given isogeneic 
cells from the peripheral blood, spleen, bone marrow, or thymus. Nor could it 
could it be shown that isogeneic cells  derived from the spleen or bone marrow 
and given in inocula of 4-64 X  106 nucleated cells 24 hr after cyclophosphamide 
or mechlorethamine altered the mortality caused by these drugs (e.g., Fig. 2). 
DISCUSSION 
Graft versus host reactions have been observed in several species, including 
man (10, 11, 18). They occur when recipient animals are unable to reject grafts 
of foreign immunologically competent cells due to immunologic immaturity, 
genetic  unresponsiveness,  or  prior immunosuppressive treatment with  whole 
body irradiation. The work of Billingham and Brent (1,  2), and Simonsen (4) 
in newborn and embryo mice and chickens did much to establish the immunologic 
nature of this disorder. For example, from their studies of the "runting disease" ALBERT  H. OWENS,  JR.~ AND  GEORGE  W.  SANTOS  287 
caused by the grafting of adult spleen cells of various allogeneic strains to new- 
born mice,  Billingham  and Brent concluded that  "runting"  resulted from an 
immunologic attack of donor immunoresponsive ceils on the recipient. Working 
with adult mice,  Vos et al.  (6) and Oliner  et al.  (7) added to this concept by 
showing that a similar wasting disorder developed in F1 hybrid recipients grafted 
with large doses (>  10  s nucleated cells) of immunocompetent cells from either 
parent. Trentin (8) and van Bekkum (9) identified  an analogous disorder in the 
F1 hybrid partner following parabiotic union with a mouse of a parental strain. 
More recently, Aisenberg et al. (12) described the induction of graft versus host 
disease in adult rats who had been thymectomized as newborns and inoculated 
with foreign spleen cells when 9-13 wk of age. In addition, numerous instances 
of graft versus host disease have been documented in  a  variety  of  animal 
species when foreign bone marrow of lymphoid tissue is grafted to adult recip- 
ients previously treated with whole body irradiation  (10,  11). 
The acute wasting syndrome described in the present report occurred in adult 
mice treated with cyclophosphamide and modest inocula of foreign immuno- 
logically competent cells. Outwardly it strongly resembled the graft versus host 
disorders previously described in  adult  animals,  especially the  "acute killing 
killing  effect" noted in irradiated  animals  given allogeneic  bone marrow and 
lymph node ceUs (6, 11, 19, 20). The gross autopsy findings  of pallor,  thymus 
and lymph node atrophy, and a variable enlargement or atrophy of the spleen 
were also similar.  We have also noted analogous clinical  phenomena  in rats 
treated with cydophosphamide and foreign ceils (21). The major findings  en- 
countered in the current studies could be distinguished from the effects caused 
by drug alone. 
Cydophosphamide pretreatment is required for the induction of this variety 
of graft versus host disease and its effectiveness in this regard is dose related. 
In contrast, mechlorethamine given in comparable doses is ineffective.  It is of 
interest that sublethal doses of cyclophosphamide are sufficient for the induction 
of graft versus host disease. In general, higher doses (in terms of their relative 
lethality)  of whole body irradiation  are required when such small inocula of 
foreign cells are given (10, 11). 
Cyclophosphamide has been shown to be a potent immunosuppressive drug 
in several species  (22)  and may be used to inhibit the formation of humoral 
antibody and prolong the survival of foreign skin and tumor grafts in rodents 
(23-30). Further, the present experiments indicate that cyclophosphamide can 
inhibit the rejection of rat granulocytes by mice. When carefully compared with 
cyclophosphamide,  mechiorethamine  has  been  found  to  be  a  less  effective 
immunosuppressant  (22). Indeed, in rats and mice mechlorethamine failed to 
suppress the primary antibody response to sheep erythrocytes even when given 
in lethal doses (29, 30). Similarly,  in the current studies, mechiorethamine was 
unable to inhibit the rejection of rat granulocytes when used at an Lr~z level. 
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phosphamide to its effectiveness in facilitating the induction of graft versus host 
disease following inoculations of allogeneic  or xenogeneic  cells, this argument 
does not seem appropriate to the similar syndrome which follows the grafting of 
homozygous parental cells to the F1 hybrid where there is genetic tolerance of 
donor  cells by the  host.  Despite this  genetic  tolerance,  modest numbers  of 
immunologieally competent cells (up to  106 or  l0  T) from  the parent  cannot 
cause a lethal graft versus host disease in normal adult hybrid mice whereas 
they can in newborn or embryo hybrid recipients (18). In studies of radiation 
chimeras,  workers have visualized whole body irradiation as providing "space" 
in the adult hybrid recipient for parental cells to lodge and prolierate and thus 
give rise to graft versus host disease (31, 32). The nature of this space or polifera- 
five stimulus is not clear, but it is not thought by most investigators to be an 
immunologic  phenomenon. 
With this in mind,  the contrasting  effectiveness  of  cyclophosphamide  and 
mechlorethamine  in the induction of graft versus host disease in the current 
studies involving parent to hybrid grafts is interesting  to contemplate.  Both 
alkylating agents when given at the dose levels used in these studies cause a 
prompt lymphopenia and a marked decrease in the size of the lymph nodes, 
spleen, and thymus. Thus, one might expect that both drugs would be effective 
in the induction of graft versus host disease since they both provide a great deal 
of "space" within the lymphoid tissues of the recipient animals. 
The presence of distinctive "recessive" antigens in the homozygous cells would 
provide one possible explanation linking the immunosuppressive characteristics 
of cyclophosphaxnide  to its role in the induction of graft versus host disease in 
adult hybrid mice given cells from either parent. Cudkowicz (33) has furnished 
data  which  suggest  the  existence of recessive  transplantation  antigens.  His 
findings,  however, have  not been confirmed  by other investigators.  Further, 
the report (34) that adult BALB/c mice treated with cyclophosphamide  and 
(BALB/c X  DBA)F1 spleen  cells did not develop graft versus host disease 
despite  the  establishment  of  chimerism  does  not  support  the  existence  of 
recessive antigens in parental cells. 
A second requirement for the induction of this type of graft versus host dis- 
order is the grafting of genetically dissimilar  immunoresponsive cells. This has 
been demonstrated by the ability of viable parental  (C57BL/6 and DBA/2), 
allogeneic  (C3H and BALB/c), and xenogeneic (Sprague-Dawley rat) periph- 
eral blood, spleen, bone marrow, and thymus cells to evoke this disorder.  An 
analogous  wasting  disease  did  not  develop when  cyclophosphamide-treated 
mice were given saline,  lysed, or heat-killed foreign cells in place of similar 
viable ones. Neither did comparable inocula of viable  isogeneic  (BDF1)  cells 
initiate the disease. 
In all experiments employing graded doses of viable foreign  spleen  cells, a 
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inoculum and the resultant severity of the graft versus host disorder. The larger 
cell inocula resulted in a more severe disease. In the studies using graded doses 
of viable parental (C57BL/6) cells obtained from the peripheral blood, spleen, 
bone marrow, and thymus, a  similar dose-response relationship was encoun- 
tered. Further, it was found that cell suspensions from the blood were the most 
potent inducers of the wasting syndrome. Thymus cell inocula were least effec- 
tive and bone marrow and spleen cells increasingly more potent in that order. It 
is of interest that the relative potency of these tissues to initiate graft versus 
host disease is analogous to their ability to produce humoral antibody when 
adoptively transferred  to  cyclophosphamide-treated mice  (13)  and  to  their 
ability to induce tolerance and runt disease in neonatal mice (35).  Similarly, it 
has been shown that foreign lymphoid cells are more effective than comparable 
numbers of cells from bone marrow in initiating graft versus host disease in 
lethally X-irradiated recipient animals (6,  11, 19, 20). 
The  prolonged  persistence  of  rat  granulocytes in  cydophosphamide-pre- 
treated host mice suggests that it is possible for other types of foreign cells to 
survive including those capable of immunologic responsiveness. Indeed, we have 
documented  prolonged  cydophosphamide-induced  lymphoid  chimerism  in 
mice (36)  as have G1ynn et al. (34).  Further we have proven the presence of 
long-term lymphoid and hematopoietic chimerism in rats treated  with lethal 
doses of cyclophosphamide and allogeneic bone marrow (37). 
SUMMARY 
In  these  studies  adult  mice  treated  with  cydophosphamide  and  foreign 
immunologically competent cells developed a  graft versus host disease which 
outwardly resembled  that  encountered in  other  experimental systems.  Pro- 
gressively larger doses of cyclophosphamide produced an increasingly severe 
disease whereas  comparable  doses  of mechlorethamine were  ineffective. In- 
creasingly larger cell inocula from parental, allogeneic, and xenogeneic donors 
resulted in  a  correspondingly more  severe disease. Nucleated cells obtained 
from the peripheral blood were found to be the most potent inducers of this 
syndrome, while cells from the spleen, bone marrow, and thymus displayed les- 
ser degrees of reactivity in that order. No such graft versus host disease occurred 
in mice given saline, lysed, or heat-killed cells in place of viable foreign cells. 
Neither did the disorder develop when comparable inocula of isogeneic cells 
were used. 
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